Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.

Pascal Boisier (1) , Pierre Nicolas (2) , Saacou Djibo (1) , Muhamed-Kheir Taha (3) , Isabelle Jeanne (1) , Halima Boubacar Maïnassara (1) , Bernard Tenebray (2) , Kiari Kaka Kairo (4) , Dario Giorgini (3) , Suzanne Chanteau (1)

1 CERMES - Centre de Recherche Médicale et Sanitaire (Niamey, Niger)
2 Institut de Médecine Tropicale du Service de Santé des Armées
3 Neisseria
4 Division du Système National d'Information Sanitaire

This is, to our knowledge, the first report of such a high incidence of NmX meningitis, although an unusually high incidence of NmX meningitis was also observed in the 1990s in Niamey. The increasing incidence of NmX meningitis is worrisome, because no vaccine has been developed against this serogroup. Countries in the African meningitis belt must prepare to face this potential new challenge.

Domains: Life Sciences [q-bio]; Biochemistry, Molecular Biology

Pascal Boisier, Pierre Nicolas, Saacou Djibo, Muhamed-Kheir Taha, Isabelle Jeanne, et al.. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.. Clinical Infectious Diseases, 2007, 44 (5), pp.657-63. ⟨10.1086/511646⟩. ⟨pasteur-00561840⟩